Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Taylor

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The International Journal on Drug Policy|April 13, 2020
The impact of legislation on acute synthetic cannabinoid harms resulting in ambulance attendanceJasmin Grigg, Jessica J Killian, Sharon Matthews, et al.
Molecular and Cellular Endocrinology|April 17, 2012
Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunctionJessica R Weaver, Theodore R Holman, Yumi Imai, et al.
Diabetologia|November 24, 2014
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunctionDavid A Taylor-Fishwick, Jessica Weaver, Lindsey Glenn, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 29, 2022
Utility of prehospital electrocardiogram interpretation in ST-segment elevation myocardial infarction utilizing computer interpretation and transmission for interventional cardiologist consultationAmir Faour, Callum Cherrett, Oliver Gibbs, et al.
Journal of the American Heart Association|June 29, 2022
Late Outcomes of Patients With Prehospital ST-Segment Elevation and Appropriate Cardiac Catheterization Laboratory NonactivationAmir Faour, Reece Pahn, Callum Cherrett, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2017
12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic IsletsKaiwen Ma, An Xiao, So Hyun Park, et al.
Journal of Medicinal Chemistry|July 12, 2011
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenaseVictor Kenyon, Ganesha Rai, Ajit Jadhav, et al.
Plos One|February 26, 2013
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes developmentShamina M Green-Mitchell, Sarah A Tersey, Banumathi K Cole, et al.
Journal of Medicinal Chemistry|January 8, 2014
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseDiane K Luci, J Brian Jameson, Adam Yasgar, et al.
Nature Chemical Biology|December 24, 2005
Monocarboxylate transporter MCT1 is a target for immunosuppressionClare M Murray, Raymond Hutchinson, John R Bantick, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The International Journal on Drug Policy|April 13, 2020
The impact of legislation on acute synthetic cannabinoid harms resulting in ambulance attendanceJasmin Grigg, Jessica J Killian, Sharon Matthews, et al.
Molecular and Cellular Endocrinology|April 17, 2012
Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunctionJessica R Weaver, Theodore R Holman, Yumi Imai, et al.
Diabetologia|November 24, 2014
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunctionDavid A Taylor-Fishwick, Jessica Weaver, Lindsey Glenn, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 29, 2022
Utility of prehospital electrocardiogram interpretation in ST-segment elevation myocardial infarction utilizing computer interpretation and transmission for interventional cardiologist consultationAmir Faour, Callum Cherrett, Oliver Gibbs, et al.
Journal of the American Heart Association|June 29, 2022
Late Outcomes of Patients With Prehospital ST-Segment Elevation and Appropriate Cardiac Catheterization Laboratory NonactivationAmir Faour, Reece Pahn, Callum Cherrett, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2017
12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic IsletsKaiwen Ma, An Xiao, So Hyun Park, et al.
Journal of Medicinal Chemistry|July 12, 2011
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenaseVictor Kenyon, Ganesha Rai, Ajit Jadhav, et al.
Plos One|February 26, 2013
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes developmentShamina M Green-Mitchell, Sarah A Tersey, Banumathi K Cole, et al.
Journal of Medicinal Chemistry|January 8, 2014
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseDiane K Luci, J Brian Jameson, Adam Yasgar, et al.
Nature Chemical Biology|December 24, 2005
Monocarboxylate transporter MCT1 is a target for immunosuppressionClare M Murray, Raymond Hutchinson, John R Bantick, et al.
Pageof 8